Medical Research
(H124)
IRS Verified
DX Registered
990 on File
THE ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION
Financial strength (30%)
79/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
AFTD’s mission is to improve the quality of life of people affected by FTD and drive research to a cure. We work every day to advance: Research. We promote and fund research toward diagnosis, treatment and a cure. Awareness. We stimulate greater public awareness and understanding. Support. We provide information and support to those directly impacted. Education. We promote and provide education for healthcare professionals. Advocacy. We advocate for research and appropriate, affordable services.
Financial Overview — FY 2024
$13.1M
Total Revenue
$11.5M
Total Expenses
$50.6M
Net Assets
55
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.1%
Fundraising Efficiency
737.5%
Operating Reserve
52.66x
Liability-to-Asset
6.3%
Revenue Diversification
94.1%
Executive Compensation
$672K
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.1% | 82.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.7% | 12.7% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
9.3% | 0.7% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
737.5% | 693.4% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
52.7 mo | 14.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
6.3% | 21.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
94.1% | 90.8% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
53.9% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
19.3% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
12.3% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $13.1M | $11.5M | $50.6M | 86.1% | 55 |
| 2023 | $8.5M | $9.7M | $45.1M | 81.1% | 47 |
| 2022 | $12.1M | $8.6M | N/A | — | 35 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.